Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
0.74 (1y: -54%)
Market Cap 30 M P/E(ttm)
Enterprise Value 44.66 M P/B 7.40
BONE- AMEX (USA)
Bacterin International Holdings, Inc.
Not Rated
Top Ranked Predictable Companies
$0.74
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry		 vs
history
Cash to Debt 0.33
BONE's Cash to Debt is ranked lower than
75% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3750.67 vs. BONE: 0.33 )
BONE' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.33
Equity to Asset 0.084
BONE's Equity to Asset is ranked lower than
78% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.53 vs. BONE: 0.084 )
BONE' s 10-Year Equity to Asset Range
Min: -3.31   Max: 0.18
Current: 0.08
-3.31
0.18
F-Score: 1
Z-Score: -1.01
M-Score: -2.32
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry		 vs
history
Operating margin (%) -15.00
BONE's Operating margin (%) is ranked lower than
52% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. BONE: -15.00 )
BONE' s 10-Year Operating margin (%) Range
Min: -55.9   Max: 3.4
Current: -15
-55.9
3.4
Net-margin (%) -23.4
BONE's Net-margin (%) is ranked lower than
75% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.25 vs. BONE: -23.4 )
BONE' s 10-Year Net-margin (%) Range
Min: -126.3   Max: 2.7
Current: -23.4
-126.3
2.7
ROE (%) -182.2
BONE's ROE (%) is ranked lower than
79% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 4.80 vs. BONE: -182.2 )
BONE' s 10-Year ROE (%) Range
Min: -182.2   Max: 8.2
Current: -182.2
-182.2
8.2
ROA (%) -22.4
BONE's ROA (%) is ranked lower than
78% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. BONE: -22.4 )
BONE' s 10-Year ROA (%) Range
Min: -123.5   Max: 5.8
Current: -22.4
-123.5
5.8
ROC (Joel Greenblatt) (%) -28.40
BONE's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 14.00 vs. BONE: -28.40 )
BONE' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -62.3   Max: 0.1
Current: -28.4
-62.3
0.1
» BONE's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

BONE Guru Trades in

BONE Guru Trades in

Q2 2011

BONE Guru Trades in Q2 2011

Steven Cohen 70,400 sh (New)
» More
Q3 2011

BONE Guru Trades in Q3 2011

Steven Cohen Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with BONE



No Insider Trades Found!

Ratios

vs
industry		 vs
history
P/B 7.40
BONE's P/B is ranked lower than
84% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. BONE: 7.40 )
BONE' s 10-Year P/B Range
Min: 5.7   Max: 259.33
Current: 7.4
5.7
259.33
P/S 1.00
BONE's P/S is ranked higher than
56% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. BONE: 1.00 )
BONE' s 10-Year P/S Range
Min: 0.87   Max: 28.81
Current: 1
0.87
28.81
EV-to-EBIT 32.3
BONE's EV-to-EBIT is ranked higher than
83% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 16.25 vs. BONE: 32.3 )
BONE' s 10-Year EV-to-EBIT Range
Min: 260   Max: 366.5
Current: 32.3
260
366.5

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 2.9
BONE's Price/Net Current Asset Value is ranked higher than
61% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. BONE: 2.9 )
BONE' s 10-Year Price/Net Current Asset Value Range
Min: 4.6   Max: 50
Current: 2.9
4.6
50
Price/Tangible Book 11.2
BONE's Price/Tangible Book is ranked higher than
92% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. BONE: 11.2 )
BONE' s 10-Year Price/Tangible Book Range
Min: 17.9   Max: 26
Current: 11.2
17.9
26
Price/Median PS Value 0.3
BONE's Price/Median PS Value is ranked higher than
51% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. BONE: 0.3 )
BONE' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 7.2
Current: 0.3
0.5
7.2

Business Description

Bacterin International Holdings, Inc. is a Delaware Corporation. The Company develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold and promote bone and other tissue growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and cartilage regeneration in knee and other joint surgeries. The Company's device division develops anti-microbial coatings to inhibit infection based upon proprietary knowledge of the phenotypical changes made by microbes as they sense and adapt to changes in their environment. Bacterin develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include the inhibition of biofilm formation, local (as opposed to systemic) drug delivery, local (as opposed to systemic) pain management, and anti-thrombotic factors for medical device applications.
Company Website
SEC Reports
Industry: Medical Devices
Compare:
» More Articles for BONE

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: GSVC, PSTB, BONE, ORIT May 09 2011 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial